China · Delayed Price · Currency is CNY Jafron Biomedical Statistics
Total Valuation
SHE:300529 has a market cap or net worth of CNY 18.41 billion. The enterprise value is 17.62 billion.
| Market Cap | 18.41B |
| Enterprise Value | 17.62B |
Important Dates
The last earnings date was Friday, August 29, 2025.
| Earnings Date | Aug 29, 2025 |
| Ex-Dividend Date | May 26, 2025 |
Share Statistics
SHE:300529 has 774.36 million shares outstanding. The number of shares has decreased by -3.13% in one year.
| Current Share Class | 774.36M |
| Shares Outstanding | 774.36M |
| Shares Change (YoY) | -3.13% |
| Shares Change (QoQ) | -4.77% |
| Owned by Insiders (%) | 50.98% |
| Owned by Institutions (%) | 15.21% |
| Float | 374.23M |
Valuation Ratios
The trailing PE ratio is 27.95 and the forward PE ratio is 20.54.
| PE Ratio | 27.95 |
| Forward PE | 20.54 |
| PS Ratio | 7.95 |
| PB Ratio | 5.90 |
| P/TBV Ratio | 6.10 |
| P/FCF Ratio | 28.59 |
| P/OCF Ratio | 21.92 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.31, with an EV/FCF ratio of 27.36.
| EV / Earnings | 26.81 |
| EV / Sales | 7.61 |
| EV / EBITDA | 19.31 |
| EV / EBIT | 22.42 |
| EV / FCF | 27.36 |
Financial Position
The company has a current ratio of 3.56, with a Debt / Equity ratio of 0.45.
| Current Ratio | 3.56 |
| Quick Ratio | 3.04 |
| Debt / Equity | 0.45 |
| Debt / EBITDA | 1.53 |
| Debt / FCF | 2.17 |
| Interest Coverage | 13.56 |
Financial Efficiency
Return on equity (ROE) is 21.15% and return on invested capital (ROIC) is 10.64%.
| Return on Equity (ROE) | 21.15% |
| Return on Assets (ROA) | 9.16% |
| Return on Invested Capital (ROIC) | 10.64% |
| Return on Capital Employed (ROCE) | 17.37% |
| Revenue Per Employee | 926,445 |
| Profits Per Employee | 262,965 |
| Employee Count | 2,797 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 1.43 |
Taxes
In the past 12 months, SHE:300529 has paid 156.52 million in taxes.
| Income Tax | 156.52M |
| Effective Tax Rate | 19.36% |
Stock Price Statistics
The stock price has decreased by -6.08% in the last 52 weeks. The beta is 0.43, so SHE:300529's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 |
| 52-Week Price Change | -6.08% |
| 50-Day Moving Average | 23.42 |
| 200-Day Moving Average | 25.01 |
| Relative Strength Index (RSI) | 51.48 |
| Average Volume (20 Days) | 12,264,339 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300529 had revenue of CNY 2.32 billion and earned 657.41 million in profits. Earnings per share was 0.85.
| Revenue | 2.32B |
| Gross Profit | 1.85B |
| Operating Income | 786.25M |
| Pretax Income | 808.62M |
| Net Income | 657.41M |
| EBITDA | 910.06M |
| EBIT | 786.25M |
| Earnings Per Share (EPS) | 0.85 |
Balance Sheet
The company has 2.19 billion in cash and 1.40 billion in debt, giving a net cash position of 790.16 million or 1.02 per share.
| Cash & Cash Equivalents | 2.19B |
| Total Debt | 1.40B |
| Net Cash | 790.16M |
| Net Cash Per Share | 1.02 |
| Equity (Book Value) | 3.12B |
| Book Value Per Share | 4.03 |
| Working Capital | 1.89B |
Cash Flow
In the last 12 months, operating cash flow was 840.00 million and capital expenditures -195.86 million, giving a free cash flow of 644.15 million.
| Operating Cash Flow | 840.00M |
| Capital Expenditures | -195.86M |
| Free Cash Flow | 644.15M |
| FCF Per Share | 0.83 |
Margins
Gross margin is 79.95%, with operating and profit margins of 33.95% and 28.38%.
| Gross Margin | 79.95% |
| Operating Margin | 33.95% |
| Pretax Margin | 34.91% |
| Profit Margin | 28.38% |
| EBITDA Margin | 39.29% |
| EBIT Margin | 33.95% |
| FCF Margin | 27.81% |
Dividends & Yields
This stock pays an annual dividend of 0.80, which amounts to a dividend yield of 3.36%.
| Dividend Per Share | 0.80 |
| Dividend Yield | 3.36% |
| Dividend Growth (YoY) | 100.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 98.71% |
| Buyback Yield | 3.13% |
| Shareholder Yield | 6.50% |
| Earnings Yield | 3.57% |
| FCF Yield | 3.50% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 20, 2020. It was a forward split with a ratio of 1.9.
| Last Split Date | May 20, 2020 |
| Split Type | Forward |
| Split Ratio | 1.9 |
Scores
SHE:300529 has an Altman Z-Score of 7.85 and a Piotroski F-Score of 7.
| Altman Z-Score | 7.85 |
| Piotroski F-Score | 7 |